PSMC3IP and ovarian carcinoma: Importantly, GT198 mutations lead to its protein overexpression, which can be detected in angiogenic pericytes and their descendent vascular smooth muscle cell lineage, such as myoepithelial cells and adipocytes in breast cancer [34], theca cells in ovarian cancer [35], and myofibroblasts in prostate and bladder cancers [36].